Glucose metabolism, schizophrenia, and antipsychotic drugs: comments to the paper of Dwyer et al.
Baptista
T
T
Department of Physiology, Los Andes University Medical School, Mèrida, Venezuela. baptri@douglas.mcgill.ca
Beaulieu
S
S
D000818:Animals; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003924:Diabetes Mellitus, Type 2 / Q000139:chemically induced; D005947:Glucose / Q000378:metabolism*; D006801:Humans; D006943:Hyperglycemia / Q000139:chemically induced; D007328:Insulin / Q000378:metabolism; D009765:Obesity / Q000139:chemically induced; D012559:Schizophrenia / Q000188:drug therapy* / Q000378:metabolism*
D014150:Antipsychotic Agents; D007328:Insulin; D005947:Glucose